21218 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen; Proteins MHC molecules or ligands thereof
Ultrapurified Phospholipoproteomic Composition for High-Purity Biomolecular Research and Precision Therapeutics
#2MODIFIED MAMMALIAN VESICLES AND COMPOSITIONS AND METHODS RELATED THERETO
#3NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
#4SYSTEMS, FORMULATIONS AND METHODS FOR GENERATING UNIVERSAL PEPTIDE/MHC COMPLEXES WITH ENGINEERED DISULFIDE CONNECTING THE HEAVY AND LIGHT CHAINS
#5ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF
#6T CELL EPITOPES ASSOCIATED WITH TYPE 1 DIABETES
#7Panel comprising Borrelia MHC multimers
#8LENTIVIRAL VECTORS TARGETING ANTIGENS TO MHC-II PATHWAY AND INDUCING PROTECTIVE CD8+ AND CD4+ T-CELL IMMUNITY IN A HOST
#9THERAPEUTIC RNA FOR LUNG CANCER
#10MHC Class II Protein Constructs
#11ANTI-TUMOUR RESPONSES TO CYTOKERATINS
#12THERAPEUTIC RNA FOR HPV-POSITIVE CANCER
#13Cellular Adjuvants for Viral Infection
#14ALPHAVIRUS ANTIGEN VECTORS
#15PRAME IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING PRAME IMMUNOGENIC PEPTIDES, AND USES THEREOF
#16T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof
#17MHC IB-MEDIATED MYELIN-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR MULTIPLE SCLEROSIS AND MOG ANTIBODY DISEASE
#18POLYNUCLEOTIDE VACCINES AND METHODS OF USING THE SAME
#19MHC IB-MEDIATED ISLET-ANTIGEN-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR TYPE 1 DIABETES
#20MHC IB-MEDIATED AQUAPORIN 4 (AQP4)-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR NMO
#21MHC IB-MEDIATED ALPHA-SYNUCLEIN-SPECIFIC TOLERANCE INDUCTION AS A NOVEL TREATMENT FOR PARKINSON'S DISEASE
#22SYSTEMS AND METHODS FOR CHAPERONE-MEDIATED LIGAND EXCHANGE ON MHC-I AND MHC-RELATED MOLECULES USING CHICKEN TAPBPR
#23IMMUNOTHERAPY WITH B*08 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS
#24COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#25RECOMBINANT pMHC CLASS II MOLECULES
#26T Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof
#27T Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof
#28IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
#29NANOPARTICLES FOR ANTIGEN-SPECIFIC CELL PROGRAMMING AND USES THEREOF
#30Method Of Validating The Triggering Of An Immune Response To A Neoepitope Of A Tumor With T-Cells
#31Cellular Adjuvants for Viral Infection
#32Cellular Adjuvants for Viral Infection
#33MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
#34ASSAY TO MEASURE THE POTENCY OF RECEPTOR-LIGAND INTERACTIONS IN NANOMEDICINES
#35MHC CLASS II T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
#36T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof
#37T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
#38SARS-COV-2 PROTEIN-DERIVED PEPTIDE AND VACCINE CONTAINING SAME
#39Alphavirus neoantigen vectors
#40METHODS AND COMPOSITIONS COMPRISING MHC CLASS PEPTIDES
#41COMBINATIONS OF MHC CLASS IB MOLECULES AND PEPTIDES FOR TARGETED THERAPEUTIC IMMUNOMODULATION
#42VACCINE
#43MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof
#44COMPOSITION COMPRISING ANTIGEN-PRESENTING CELL CO-EXPRESSING MHC AND TUMOR ANTIGEN, AND CANCER TREATMENT USING SAME
#45T CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
#46SARS-COV-2 VACCINES
#47MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#48Antigen presenting scaffolds for immune-cell manipulation
#49T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#50Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
#51Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
#52PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF
#53INDIVIDUALIZED VACCINES FOR CANCER
#54MHC RESTRICTED IMMUNOGENIC TELOMERASE REVERSE TRANSCRIPTASE -SPECIFIC PEPTIDES, THEIR COMPLEX CONJUGATES, AND METHODS OF USING THE SAME
#55MHC class I associated peptides for prevention and treatment of zika virus
#56T-CELL MODULATORY MULTIMERIC POLYPEPTIDES WITH CONJUGATION SITES AND METHODS OF USE THEREOF
#57METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY
#58RECOMBINANT PMHC MOLECULES
#59Cellular adjuvants for viral infection
#60SYSTEMS AND METHODS FOR MHC CLASS II EPITOPE PREDICTION
#61PRODUCTION OF MHC II/CII COMPLEXES
#62TUMOR-ASSOCIATED ANTIGEN-SPECIFIC T CELL RESPONSES
#63ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF
#64Alphavirus antigen vectors
#65Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof
#66Vaccine
#67Vaccine
#68T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#69PEPTIDE-INDUCED NK CELL ACTIVATION
#70Panel comprising MHC multimers
#71PERSONALISED IMMUNOGENIC PEPTIDE IDENTIFICATION PLATFORM
#72Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
#73Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods
#74TELEOST INVARIANT CHAIN CANCER VACCINE
#75Immunotherapy against several tumors including neuronal and brain tumors
#76PEPTIDES FROM NPSR1
#77Immunotherapy against several tumors including neuronal and brain tumors
#78Immunotherapy against several tumors including neuronal and brain tumors
#79Immunotherapy against several tumors including neuronal and brain tumors
#80NUCLEOTIDE VACCINE
#81IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
#82METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS
#83NOVEL NUCLEIC ACID MOLECULES
#84COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#85PEPTIDES DERIVED FROM PROSTATE SPECIFIC ANTIGEN (KLK3) AND COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES
#86PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF
#87PROGESTERONE-ASSOCIATED ENDOMETRIAL PROTEIN (PAEP) AND USES THEREOF
#88Method of validating the triggering of an immune response to a neoepitope of a tumor with t-cells
#89VACCINE DEVELOPMENT METHODOLOGY BASED ON AN ADHESION MOLECULE
#90PEPTIDES FROM PIWIL1
#91PEPTIDES DERIVED FROM KALLIKREIN 4
#92PEPTIDES
#93METHODS OF TREATING AUTOIMMUNE DISEASE
#94Compositions and methods for immunotherapy
#95MHC class I associated peptides for prevention and treatment of zika virus
#96Synthetic conjugate of CpG DNA and T-help/CTL peptide
#97Alphavirus neoantigen vectors
#98Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods
#99COMBINATIONS OF MHC CLASS IB MOLECULES AND PEPTIDES FOR TARGETED THERAPEUTIC IMMUNOMODULATION
#100Lipid A mimics, methods of preparation, and uses thereof
#101Method for the detection, preparation and depletion of CD4+ t lymphocytes
#102Antigen-specific tolerance and compositions for induction of same
#103Cellular adjuvants for viral infection
#104Nanoscale artificial antigen presenting cells
#105Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif
#106ASSAY TO MEASURE THE POTENCY OF RECEPTOR-LIGAND INTERACTIONS IN NANOMEDICINES
#107NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF
#108Methods and compositions for treating multiple sclerosis and related disorders
#109ENGINEERED INVARIANT CHAIN MOLECULE FOR IMPROVED MHC CLASS I LOADING
#110Fusion peptides with antigens linked to short fragments of invariant chain(CD74)
#111IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE
#112C5 IMMUNIZATION FOR AUTOLOGOUS ANTI-C5 ANTIBODY PRODUCTION
#113Molecular Complex for Targeting Antigens Towards Cells Comprising Antigens and Uses Thereof for Vaccination
#114Antigen presenting scaffolds for immune-cell manipulation
#115Vaccine
#116COMPOSITIONS FOR AND METHODS OF TREATING AND PREVENTING CANCER TARGETING TUMOR ASSOCIATED CARBOHYDRATE ANTIGENS
#117Individualized vaccines for cancer
#118PEPTIDES
#119NEOANTIGEN COMPOSITIONS AND METHODS OF USING THE SAME IN IMMUNOONCOTHERAPY
#120Methods and compositions for sustained immunotherapy
#121Nucleic acid molecules
#122NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
#123T cell receptors specific for the NY-ESO-1 tumor antigen-HLA-A*02 complex
#124Reversible protein multimers, methods for their production and use
#125PEPTIDES
#126PEPTIDES FROM NPSR1
#127ANTI-HLA ASSAY AND METHODS
#128Synthetic conjugate of CpG DNA and T-help/CTL peptide
#129COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#130Antibody Fusion Protein and Preparation Method and Use Thereof
#131Antigen-specific tolerance and compositions for induction of same
#132Compositions for generation of immune tolerance to specific antigens
#133Compositions for inducing antigen-specific tolerance
#134Compositions and methods for enhancing an immune response
#135Lipid A mimics, methods of preparation, and uses thereof
#136COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#137Methods and compositions for treating multiple sclerosis and related disorders
#138Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
#139Antigen delivery system
#140RECOMBINANT T CELL RECEPTOR LIGAND COMPOSITIONS AND METHODS FOR TREATMENT OF PROSTATE CANCER
#141USE OF LEUKOCYTES AND NOVEL BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION, AND TREATMENT OF A NEUROLOGICAL DISORDER
#142Cellular vaccine and method of inducing an immune response in a subject
#143ENGINEERED INVARIANT CHAIN MOLECULE FOR IMPROVED MHC CLASS I LOADING
#144Immunotherapy against several tumors including neuronal and brain tumors
#145Immunotherapy against several tumors including neuronal and brain tumors
#146Immunotherapy against several tumors including neuronal and brain tumors
#147Immunotherapy against several tumors including neuronal and brain tumors
#148Immunotherapy against several tumors including neuronal and brain tumors
#149Immunotherapy against several tumors including neuronal and brain tumors
#150Methods for reducing immune responses
#151Immunotherapy against several tumors including neuronal and brain tumors
#152Compositions for inducing antigen-specific tolerance
#153Methods for induction of antigen-specific immune tolerance
#154Compositions for generating immune tolerance by targeting erythrocytes
#155COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#156Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid Compositions
#157Compositions for and methods of treating and preventing targeting tumor associated carbohydrate antigens
#158On demand vesicle formation from vesicle precursors suitable for long-term storage
#159COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#160Individualized vaccines for cancer
#161Nanoscale artificial antigen presenting cells
#162DIRECTED IMMUNE STIMULATION
#163Synthetic conjugate of CpG DNA and T-help/CTL peptide
#164Compositions and methods using recombinant MHC molecules for the treatment of stroke
#165Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof
#166METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS
#167Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif
#168Cellular vaccine and method of inducing an immune response in a subject
#169Methods and compositions for treating multiple sclerosis and related disorders
#170Methods and compositions for sustained immunotherapy
#171Immunotherapy against several tumors including neuronal and brain tumors
#172Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes
#173Recombinant polypeptides comprising MHC class II α1 domains
#174Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
#175Gene coded for a MHC class I molecule, plasmid, expression system protein, multimer, reagent and kit to analyze a T cell frequency
#176Reversible protein multimers, methods for their production and use
#177Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
#178Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination
#179Prevention And Treatment Of Amyloidogenic Disease
#180Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
#181EPITOPE TESTING USING SOLUBLE HLA
#182ANTI-HLA ASSAY AND METHODS
#183Botulinum neurotoxin antigenic compositions and methods
#184COMPARATIVE LIGAND MAPPING FROM MHC CLASS I POSITIVE CELLS
#185COMPARATIVE LIGAND MAPPING FROM MHC POSITIVE CELLS
#186Treatment of retinal disorders with recombinant T cell receptor ligand (RTL)
#187Prevention and Treatment of Amyloidogenic Disease
#188Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
#189Erythrocyte-binding therapeutics
#190Immunotherapy against several tumors including neuronal and brain tumors
#191MOLECULAR COMPLEXES WHICH MODIFY IMMUNE RESPONSES
#192Method for the purification of protein complexes
#193ANTIBODIES AS T CELL RECEPTOR MIMICS, METHODS OF PRODUCTION AND USES THEREOF
#194Artificial cells
#195Artificial cells
#196Artificial cells
#197Prevention and Treatment of Amyloidogenic Disease
#198ANTIBODIES AS T CELL RECEPTOR MIMICS, METHODS OF PRODUCTION AND USES THEREOF
#199MOLECULAR COMPLEXES WHICH MODIFY IMMUNE RESPONSES
#200MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
#201Compositions and methods using recombinant MHC molecules for the treatment of stroke
#202METHOD FOR ENHANCING AN IMMUNE RESPONSE
#203Artificial cells
#204Artificial cells
#205Artificial cells
#206EPITOPE TESTING USING SOLUBLE HLA
#207Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
#208COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#209Compositions and methods using recombinant MHC molecules for the treatment of uveitis
#210Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
#211treatment
#212NUCLEOTIDE VACCINE
#213COMPOSITIONS COMPRISING AN ANTIGEN, AN AMPHIPATHIC COMPOUND AND A HYDROPHOBIC CARRIER, AND USES THEREOF
#214Immunotherapy against several tumors including neuronal and brain tumors
#215PURIFICATION AND CHARACTERIZATION OF SOLUBLE MHC PROTEINS
#216Human papillomavirus / Ii-Key hybrids and methods of use
#217Optimized multi-epitope constructs and uses thereof
#218PRODUCTION OF BIOLOGICAL CARRIERS FOR INDUCTION OF IMMUNE RESPONSE AND INHIBITION OF VIRAL REPLICATION
#219Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors
#220CHIMERIC VACCINE ANTIGENS AGAINST THE AVIAN INFLUENZA VIRUS
#221Antibodies as T cell receptor mimics, methods of production and uses thereof
#222PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#223Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency
#224HCV F PROTEIN AND USES THEREOF
#225Methods of assaying vaccine potency
#226Compositions for Inducing Immune Response Comprising Inverted Microsomes
#227COMPOUND COMPRISING AN AUTOANTIGENIC PEPTIDE AND A CARRIER WITH A MHC BINDING MOTIF
#228Antibodies as T cell receptor mimics, methods of production and uses thereof
#229Prevention and treatment of amyloidogenic disease
#230Methods for removing anti-MHC antibodies from a sample
#231Compositions and methods for the prevention and treatment of autoimmune conditions
#232Disulfide trap MHC class I molecules and uses therefor
#233METHODS OF ASSAYING VACCINE POTENCY
#234Humanized antibodies that recognize beta amyloid peptide
#235Antibodies at T cell receptor mimics, methods of production and uses thereof
#236HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
#237PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#238Prevention and treatment of amyloidogenic disease
#239Humanized antibodies that recognize beta amyloid peptide
#240Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity
#241Expression of HLA proteins on non human cells
#242PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#243Ii-key enhanced vaccine potency
#244Humanized antibodies that recognize beta amyloid peptide
#245Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
#246Targeting of genetic vaccine vectors
#247Change of the Load State of Mhc Molecules
#248Composition for inducing immune response comprising inverted microsomes
#249Comparative ligand mapping from MHC positive cells
#250Antibodies as T cell receptor mimics, methods of production and uses thereof
#251Optimized multi-epitope constructs and uses thereof
#252Purification and characterization of soluble human HLA proteins
#253Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
#254Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune disease
#255Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
#256Peptide constructs for treating disease
#257Epitope testing using soluble HLA
#258Soluble MHC artificial antigen presenting cells
#259Prevention and treatment of amyloidogenic disease
#260Antibodies as T cell receptor mimics, methods of production and uses thereof
#261Prevention and treatment of amyloidogenic disease
#262Utilization of mhc class II binding motifs in immunization to produce immune, serum, monoclonal antibodies and vaccines
#263Targeting of genetic vaccine vectors
#264Prevention and treatment of amyloidogenic disease
#265Prevention and treatment of amyloidogenic disease
#266Humanized antibodies that recognize beta amyloid peptide
#267Prevention and treatment of amyloidogenic disease
#268Prevention and treatment of amyloidogenic disease
#269Prevention and treatment of amyloidogenic disease
#270Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency
#271Prevention and treatment of amyloidogenic disease
#272Synthetic conjugate of CpG DNA and T-help/CTL peptide
#273Prevention and treatment of amyloidogenic disease
#274Antigen presenting vesicles
#275Prevention and treatment of amyloidogenic disease
#276Prevention and treatment of amyloidogenic disease
#277Prevention and treatment of amyloidogenic disease
#278Induction of immune response against desired determinants
#279Method for inducing cytotoxic T lymphocyte
#280Prevention and treatment of amyloidogenic disease
#281Prevention and treatment of amyloidogenic disease
#282Prevention and treatment of amyloidogenic disease
#283Prevention and treatment of amyloidogenic disease
#284Prevention and treatment of amyloidogenic disease
#285Prevention and treatment of amyloidogenic disease
#286Prevention and treatment of amyloidogenic disease
#287Methods of attaching soluble HLA to solid supports
#288Comparative ligand mapping from MHC class 1 positive cells
#289Inducing cellular immune responses to using peptide and nucleic acid compositions